EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 42 filers reported holding EVELO BIOSCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2 | -94.4% | 10,883 | -51.9% | 0.00% | – |
Q4 2022 | $36 | -99.4% | 22,641 | +654.2% | 0.00% | – |
Q3 2022 | $6,000 | -64.7% | 3,002 | -39.1% | 0.00% | – |
Q1 2022 | $17,000 | -96.2% | 4,931 | -93.3% | 0.00% | – |
Q4 2021 | $448,000 | +414.9% | 73,728 | +494.0% | 0.00% | – |
Q3 2021 | $87,000 | +64.2% | 12,412 | +223.0% | 0.00% | – |
Q2 2021 | $53,000 | -74.3% | 3,843 | -80.0% | 0.00% | – |
Q1 2021 | $206,000 | +164.1% | 19,252 | +198.3% | 0.00% | – |
Q4 2020 | $78,000 | +62.5% | 6,453 | -28.6% | 0.00% | – |
Q3 2020 | $48,000 | +26.3% | 9,034 | +15.1% | 0.00% | – |
Q2 2020 | $38,000 | +123.5% | 7,848 | +73.2% | 0.00% | – |
Q1 2020 | $17,000 | -69.6% | 4,531 | -67.3% | 0.00% | – |
Q4 2019 | $56,000 | +36.6% | 13,855 | +103.2% | 0.00% | – |
Q3 2019 | $41,000 | -49.4% | 6,817 | -24.2% | 0.00% | – |
Q2 2019 | $81,000 | +161.3% | 8,991 | +130.8% | 0.00% | – |
Q1 2019 | $31,000 | +29.2% | 3,896 | +93.7% | 0.00% | – |
Q3 2018 | $24,000 | +380.0% | 2,011 | +411.7% | 0.00% | – |
Q2 2018 | $5,000 | – | 393 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |